ALPINE, UT, Feb. 8 /PRNewswire-FirstCall/ - American Biotech Labs
(ABL), a private company (Clifton Mining Company owns 22% of ABL) announces
that they have just signed a joint venture with International Minerals and
Metals, Inc. (IMM), to develop markets in 59 countries.
The New Venture
IMM is a private international company that has built a longstanding
network of joint ventures in 59 countries, under the direction of its
chairman Mr. Philip M. Lynch. This joint venture network will become the
basis for the next round of sales growth for ABL as well as for
humanitarian aid purposes. Over the last year, the management of ABL has
personally met with many of these joint venture partners in Dubai,
Singapore, China, India, and Europe, etc., in preparation for the new
ABL/IMM joint venture.
The management of ABL feels that this joint venture will open doors in
numerous countries world wide, where the SilverSol Technology(TM) products
are needed, to promote health and wellness.
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are
cautioned that forward looking statements invoke risk and uncertainties
that may affect the company's business prospects and performance.
SOURCE Clifton Mining Company